Ocular Therapeutix, Inc (OCUL): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

187.24M
Year ended 2025-12-31
+31.3%
3-year compound annual growth
+25.2%
5-year compound annual growth
2019-12-31: 45.27M2020-12-31: 60.75M2021-12-31: 82.16M2022-12-31: 82.64M2023-12-31: 85.60M2024-12-31: 158.27M2025-12-31: 187.24M187.24M
2019-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31187.24M+18.3%2026-02-05, From 2025-01-01
2024-12-31158.27M+84.9%2026-02-05, From 2024-01-01
2023-12-3185.60M+3.6%2026-02-05, From 2023-01-01
2022-12-3182.64M+0.6%2025-03-03, From 2022-01-01
2021-12-3182.16M+35.2%2024-03-11, From 2021-01-01
2020-12-3160.75M+34.2%2023-03-06, From 2020-01-01
2019-12-3145.27Mn/a2022-02-28, From 2019-01-01